• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 42 of 100
Novartis Amarin Cholesterol Drugs
Newsletters
Novartis’ $9.7 Billion Deal Sets off Heart Drug Wars
By Sy MukherjeeNovember 25, 2019
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
Finance
Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By James Paton and BloombergNovember 25, 2019
Best Drugs Last 10 Years
Newsletters
Which Medicines Have Transformed Drug Development in the Past Decade?
By Sy MukherjeeNovember 22, 2019
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
Politics
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
By Matthew Perrone and The Associated PressNovember 15, 2019
BeiGene FDA Approval Cancer
Newsletters
Chinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval
By Sy MukherjeeNovember 14, 2019
CRISPR Gene Editing Cancer Safety
Newsletters
CRISPR Gene-Editing Is Being Used to Fight Cancer—And May Be Safe
By Sy MukherjeeNovember 7, 2019
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
Politics
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
By Ricardo Alonso-Zaldivar and The Associated PressNovember 5, 2019
The Hong Kong skyline is shown at night in a layer of cloudy fog.
Finance
This 24-Year-Old Chinese Biopharma Heir Just Became an Overnight Billionaire
By Blake Schmidt, Venus Feng, Gregor Stuart Hunter and BloombergOctober 23, 2019
Biogen Alzheimers Aducanumab
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By Sy MukherjeeOctober 22, 2019
fortune logo icon (red)
Newsletters
Could Lowering Drug Prices Hamper Drug Innovation?—Brainstorm Health
By Sy MukherjeeOctober 14, 2019
China Biotech Brad Loncar
Newsletters
How China Is Transforming the Biotech Industry: Brainstorm Health
By Sy MukherjeeOctober 7, 2019
Nike Innovation For Everybody Unveiling
Health
Nike CEO Mark Parker Knew of Company-Linked Doping Experiments, U.S. Anti-Doping Agency Says
By Eben Novy-Williams and BloombergOctober 1, 2019
Ken Griffin Citadel Fox Foundation Parkinson's
Health
Exclusive: Billionaire Ken Griffin to Fund $10 Million Parkinson’s Competition With Michael J. Fox Foundation
By Sy MukherjeeSeptember 23, 2019
Congress Pelosi Drug Pricing Legislation
Newsletters
About Congress’ New Drug Pricing Legislation: Brainstorm Health
By Sy MukherjeeSeptember 19, 2019
Aimmune Peanut Allergy Treatment
Newsletters
A Pioneering Peanut Allergy Treatment on the Horizon: Brainstorm Health
By Sy MukherjeeSeptember 16, 2019
1...
  • 40
  • 41
  • 42
  • 43
  • 44
...100
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.